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Many human traits are highly correlated. This correlation can be leveraged to improve the power of genetic association tests to identify
markers associated with one or more of the traits. Principal component analysis (PCA) is a useful tool that has been widely used for the
multivariate analysis of correlated variables. PCA is usually applied as a dimension reductionmethod: the few top principal components
(PCs) explainingmost of total trait variance are tested for association with a predictor of interest, and the remaining components are not
analyzed. In this study we review the theoretical basis of PCA and describe the behavior of PCA when testing for association between a
SNP and correlated traits. We then use simulation to compare the power of various PCA-based strategies when analyzing up to 100 corre-
lated traits.We show that contrary to widespread practice, testing only the top PCs often has low power, whereas combining signal across
all PCs can have greater power. This power gain is primarily due to increased power to detect genetic variants with opposite effects on
positively correlated traits and variants that are exclusively associated with a single trait. Relative to other methods, the combined-PC
approach has close to optimal power in all scenarios considered while offering more flexibility and more robustness to potential con-
founders. Finally, we apply the proposed PCA strategy to the genome-wide association study of five correlated coagulation traits where
we identify two candidate SNPs that were not found by the standard approach.Introduction
The genetic component of common, complex diseases
such as asthma or type 2 diabetes is often studied via mul-
tiple related endo-phenotypes. The identification of ge-
netic variants that influence these correlated traits may
hold the key to understanding the genetic architecture of
the disease in question. Although many studies analyze
each of these phenotypes separately, the joint analysis of
multivariate phenotypes has recently become popular
because it can increase statistical power to detect genetic
loci.1–4 However, integrating association signals at a single
SNP over multiple correlated dependent variables in a sin-
gle comprehensive framework is not always straightfor-
ward. Simple approaches, such as Fisher’s method applied
to univariate analysis of each phenotype, can inflate the
type I error rate when the traits are correlated. Several
advanced methods that account for the correlation be-
tween phenotypes have been proposed. Some of these
methods rely on assumptions about the phenotypes or
relatedness that can limit their value in practice, and
some methods are computationally intensive and inappli-
cable to large data sets. As genotype and phenotype data
sets continue to grow, both computationally efficiency
and robustness will only become more important.
Currently, three different strategies are commonly used
for detecting genetic associations in correlated pheno-
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include mixed effects models that model the covariance
structure caused by correlated phenotypes as well as
population structure.1,5 For p value correction methods,
univariate association tests are first performed for each
phenotype individually and then combined in a meta-
analysis while accounting for the observed correlational
structure between the phenotypes.6–8 Finally, data reduc-
tionmethods consist of identifying the linear combination
of a set of variables that is the most highly correlated with
any linear combination of a second set of variables. Two
common data reduction approaches in genetic epidemi-
ology are canonical correlation analysis9 (which is equiva-
lent to a one-way MANOVA when analyzing a single SNP)
and principal component analysis (PCA), where principal
components (PCs) are built to maximize either the pheno-
typic variance or heritability.10
In this study we review the theoretical basis for standard
PCA (that maximize the phenotypic variance) and eval-
uate the performance of different PCA-based strategies
that have been commonly applied in genetic epidemiology
for linkage analysis and genome-wide association studies
(GWASs).11–18 Following the principle of dimension reduc-
tion, most studies test for associations between individual
SNPs and the first few PCs that explain most of the total
phenotypic variance. Downstream from the univariate
analysis of the top PCs, some studies also conducted a
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previous work has demonstrated the utility of PCA for
multivariate GWASs, fundamental questions remain
unanswered. First, there is no clear consensus on how
one chooses a ‘‘low-variance’’ criterion for rejection of
the component from the analysis. Second, it is unclear
whether and how one should combine associations across
PCs and how to interpret such an association. To address
these questions, we compared different PCA-based strate-
gies when analyzing a large number of simulated corre-
lated phenotypes.
Contrary to the current prevalent belief, our results show
that principal components explaining a small amount of
total phenotypic variance can be as important as those ex-
plaining large amount of variance. Interestingly, this phe-
nomenon has been suggested in a different context when
analyzing nongenetic data (e.g., Jolliffe19). In many real-
istic scenarios, these small components can capture a sub-
stantial proportion of the genetic variance. Discarding
these lower-variance PCs can, therefore, severely decrease
power to detect genetic variants associated with one or
more of the traits. In particular, we found that combining
associations across all PCs, including those explaining a
small amount of variance, is a particularly powerful strat-
egy for detecting pleiotropic genetic variants and genetic
variants that are associated with single trait that is highly
correlated with the other traits in the study.
Based on our analysis, we propose the combined PCA
strategy as a powerful, computationally efficient, and
robust method suitable for most scenarios. We compared
this approach to four other methods for analyzing corre-
lated phenotypes: MANOVA, Multiphen,20 MTMM,1 and
TATES.8We found that the combined PC approach showed
power close to optimal in all scenarios we considered while
offering more flexibility and robustness than other
methods. Finally, we confirmed the usefulness of this
approach by analyzing 5 coagulation-related quantitative
traits in 685 subjects from the MARTHA study,21,22 where
we identified two candidate variants that would have
been missed by the standard PCA approach.Material and Methods
Analysis of Two Phenotypes
For illustration, consider a hypothetical model with two positively
correlated and normally distributed phenotypes, Y1 and Y2 with
mean 0 and variance 1, which both depend on an unknown var-
iable U and a scaled genotype G that are also normally distributed
with mean 0 and variance 1. Let c denote the correlation between
Y1 and Y2 due to U and v1 and v2 denote the proportion of variance
of Y1 and Y2 explained by G, respectively. We assume that the
effects of U and G on Y1 and Y2 are positive and that (cþvmax),
where vmax is the maximum of v1 and v2, can vary within [0,1],
so that the two trait vectors can be expressed as:
y1 ¼
ﬃﬃ
c
p  uþ ﬃﬃﬃﬃﬃv1p  g þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 c  v1Þp  ε1 (Equation 1)
y2 ¼
ﬃﬃ
c
p  uþ ﬃﬃﬃﬃﬃv2p  g þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 c  v2Þp  ε2; (Equation 2)The Amwhere ε1 and ε2 denote independent random noises that are
normally distributed with mean 0 and variance 1. For this
general model, the principal components of the two traits are
pc1 ¼ 1=
ﬃﬃﬃ
2
p  ðy1 þ y2Þ and pc2 ¼ 1=
ﬃﬃﬃ
2
p  ðy1  y2Þ, which can
be rewritten as:
pc1 ¼ 1ﬃﬃﬃ
2
p 

2  ﬃﬃcp   uþ ð ﬃﬃﬃﬃﬃv1p þ ﬃﬃﬃﬃﬃv2p Þ  g
þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1 c  v1Þ
p
 ε1 þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1 c  v2Þ
p
 ε2
 (Equation 3)
pc2 ¼ 1ﬃﬃﬃ
2
p 

ð ﬃﬃﬃﬃﬃv1p  ﬃﬃﬃﬃﬃv2p Þ  g þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 c  v1Þp  ε1

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1 c  v2Þ
p
 ε2

:
(Equation 4)
The total phenotypic variance explained by pc1 and pc2
and noted by s1 and s2, respectively, can be defined as (see
Appendix A)
s1 ¼ 1þ c þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v1v2
p
2
(Equation 5)
s2 ¼ 1 c 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v1v2
p
2
: (Equation 6)
From this it follows that vpc1 and vpc2, the proportion of variance
of pc1 and pc2 explained by G, respectively, can be expressed as
(see Appendix A)
vpc1 ¼ v1 þ v2 þ 23
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v1v2
p
2  ðc þ 1þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃv1v2p Þ (Equation 7)
vpc2 ¼ v1 þ v2  23
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v1v2
p
2ð1 c  ﬃﬃﬃﬃﬃﬃﬃﬃﬃv1v2p Þ : (Equation 8)
The power of the association test betweenG and Y1, Y2, PC1, and
PC2 can then be compared for different sample size and genetic
effect. The Wald test for association is equal to N3 bv, where N is
the sample size and bv: is the estimated proportion of variance
explained by G. BecauseN3bv : follows a noncentral chi-square dis-
tribution with one degree of freedom (df) and a noncentral param-
eter equal to d ¼ N3v:, the power is23
Power ¼ 1 F

c21;1a;0 j1; d

(Equation 9)
Here, Fðc2jd; dÞ is the cumulative distribution function for the
noncentral chi-square distribution with d degrees of freedom
and noncentrality parameter d; c2d;p;d is the inverse of F, i.e., the
quantiles of the noncentral chi-square distribution; and a is the
type I error rate. Because the two PCs are independents, one can
define a joint test of the PCs by summing the 1 df noncentral
chi-square from each PC to form a 2 df noncentral chi-square.
The power for such a test is equal to
Power ¼ 1 F

c22;1a;0 j2; d

: (Equation 10)
For simplicity, we derived the proportion of variance explained
and the power to detect a genetic association for two positively
correlated traits where the genetic effects on the traits were also
positive (and so in the same direction). Trivially, the same result
is produced when the traits are negatively correlated and the
genetic effects are in opposite direction. The extension to the
situation where the genetic effect is opposite to the correlation is
similarly straightforward.erican Journal of Human Genetics 94, 662–676, May 1, 2014 663
Analysis of Five Correlated Phenotypes
To explore the performance of different methods, we simulated
traits under four different models of correlation pattern. For each
of these, we simulated 10,000 sets of correlated traits measured
on 5,000 subjects. For each subject we generated a SNP G with
minor allele frequency of 0.3 and five phenotypes (Y1 to Y5).
The phenotypes were generated as defined in Equation 1 where c
was different for each phenotype so that the average correlation
pattern between the five phenotypes matches the following corre-
lation matrices:
model1 ¼
0BBBBB@
1 0:50 0:31 0:15 0:07
0:50
0:31
0:15
1 0:31 0:15
0:31 1 0:09
0:15 0:09 1
0:15
0:04
0:02
0:07 0:07 0:04 0:02 1
1CCCCCA;
model2 ¼
0BBBBB@
1 0:80 0:63 0:32 0:09
0:80
0:63
0:32
1 0:63 0:32
0:63 1 0:09
0:32 0:09 1
0:09
0:07
0:03
0:09 0:09 0:07 0:03 1
1CCCCCA
model3 ¼
0BBBBB@
1 0:30 0:30 0:30 0:30
0:30
0:30
0:30
1 0:30 0:30
0:30 1 0:30
0:30 0:30 1
0:30
0:30
0:30
0:30 0:30 0:30 0:30 1
1CCCCCA;
model4 ¼
0BBBBB@
1 0:70 0:70 0:70 0:70
0:70
0:70
0:70
1 0:70 0:70
0:70 1 0:70
0:70 0:70 1
0:70
0:70
0:70
0:70 0:70 0:70 0:70 1
1CCCCCA
The proportion of variance explained by the simulated genetic
variant G was drawn from a uniform distribution with minimum
0.001 andmaximum 0.005, independently of the phenotypic cor-
relation. For the pleiotropic effects, K ¼ 2,..,5 phenotypes affected
by the SNP were randomly chosen (with equal probability). We
also simulated situations where the pleiotropic effect of the SNP
reflects the phenotypic correlation pattern; that is, assuming
that the most highly correlated traits are more likely to be associ-
ated with the same genetic variants. To do so, we set the probabil-
ity that the ith phenotype was associated withG to be proportional
to its correlation with other traits. For example, in the presence of
a pleiotropic effect on two phenotypes under model 2, the two
traits Y1 and Y2, correlated at 0.8, had much higher chances to
be selected. Note that for model 3 and model 4, this does not
matter because the phenotypes are equally correlated.Combined Analysis of Venous Thrombosis-Related
Phenotypes
To demonstrate the applicability of the proposed method, we
analyzed five quantitative intermediate phenotypes for venous
thrombosis (MIM 188050) risk measured in the MARTHA study.
The study sample consists of unrelated European individuals
with venous thromboembolism, consecutively recruited at the
Thrombophilia center of La Timone Hospital (Marseille, France)
between January 1994 andOctober 2005. All individuals were gen-
otyped with the Illumina Human610-Quad and Human660W-
Quad Beadchips. Five coagulation-related phenotypes were
studied: the activated partial thromboplastin time (aPTT), the
standardized Anticoagulant response to Agkistrodon contortrix664 The American Journal of Human Genetics 94, 662–676, May 1, 2venom (ACVn), and plasma levels of three coagulation factors,
fibrinogen (FIB), factor VIII (FVIII), and von Willebrand factor
(vWF). GWASs have already been conducted for these phenotypes
with either raw genotypes or imputed SNPs from HapMap 2. A
detailed description of the cohort and the phenotypes can be
found in Oudet-Mellakh et al.,21 Antoni et al.,22 and Tang
et al.24 In this study, we imputed the genotyped by using the
1000 Genomes25 2012-02 release with the minimac software.
Only SNPs with imputation quality Rsq> 0.3 and minor allele fre-
quency (MAF) > 0.01 (n ¼ 8,862,493) were used in this study. The
imputed SNPs were tested for association with all of the pheno-
types individually and the derived PCs via a linear regression
where the allele dosages for the imputed SNPs were used. To
achieve this, we employed the mach2qtl software.26 These associ-
ation analyses were conducted in a sample of 685 individuals with
no missing phenotype information and they were adjusted for
age, sex, anticoagulant therapy, smoking, and the first four prin-
cipal components derived from the genome-wide genotypes.Results
Comparison of Power for the Analysis of Two
Phenotypes
Let us first consider the analysis of two correlated traits, Y1
and Y2 (Equations 1 and 2), where the tested SNP affects
only the first trait, Y1, and has no effect on the second,
Y2. If the genetic effect is small, such that the contribution
of the SNP on the correlation between the two traits is
negligible, then the two PCs (Equations 3 and 4) can be
approximated by
pc1z
1ﬃﬃﬃ
2
p 

2  ﬃﬃcp   uþ ð ﬃﬃﬃﬃﬃv1p Þ  g þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ2  ð1 cÞp  ε01
(Equation 11)
pc2z
1ﬃﬃﬃ
2
p 

ð ﬃﬃﬃﬃﬃv1p Þ  g þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ2  ð1 cÞp  ε02; (Equation 12)
where ε0: follow a normal distribution with mean 0 and
variance 1. Under this assumption, the proportion of the
total variance explained by PC1 and PC2 (Equations 5
and 6) become a linear function of the correlation c, i.e.,
s1 ¼ ð1þ cÞ=2 and s2 ¼ ð1 cÞ=2. Hence, s1 is approxi-
mately equal to s2 when c is small but is much larger
than s2 when c increases.
From Equations 11 and 12 we see that PC1 primarily de-
pends on the effect of U, the unmeasured variable repre-
senting the shared effect. Conversely, the effect of U is,
by construction in this example, not captured by PC2,
which depends only on the effect of the SNP on Y1 plus
some residual noise. This noise term scales with the
phenotypic correlation, decreasing dramatically with an
increasing value of c. Therefore, a test of association with
the smaller principal component, PC2, has greater power
than a test with PC1 to detect a genetic variant that affects
a single phenotype when c is different from 0. Interest-
ingly, it can also have greater power than testing for asso-
ciation with Y1, even though the genetic variant does014
Figure 1. Power to Detect a SNP Associated with a Single Trait
in a Bivariate Analysis
Power to detect the SNP associated with Y1 based on the tests of
PC1, PC2, the combined PCs, and Y1 for different sample size
and genetic effects (A and B), and proportion of phenotypic vari-
ance explained by PC1 and PC2 (C). The power of each of the
four tests is presented as a function of c the correlation between
Y1 and Y2, the sample size N, and v1 and v2, the proportion of
the variance of Y1 and Y2 explained by the SNP, respectively.not affect the second trait. This is because the ratio of ge-
netic effect over total variance can become greater in PC2
as compared to Y1, thus increasing the signal-to-noise
ratio. Indeed, the difference between Y1 and Y2 can be
viewed as a form of adjustment of Y1 for Y2 (and
conversely). When the correlation between the two traits
is large, a substantial amount of noise (the effect of U) is
removed from Y1 by subtracting Y2, while at the same
time the genetic effect remains constant because the SNP
is associated with Y1 only. Figure 1 presents a comparison
of the power for the test of association between G andThe Amrespectively PC1, PC2, and the combined PCs approach,
against the test of association between G and Y1 when
the SNP is associated with Y1 but not with Y2. In this
case the combined PC test and the test of PC2 have greater
power than the test of Y1 when the correlation is large but
lower power when the correlation is low. This gain in
power tends to be larger for the combined PCs as compared
to PC2 when the effect of G on the trait is large or when the
sample size increases (see Figure 1A). Conversely, the test of
PC2 becomes optimal when sample size or genetic effect is
small and correlation is larger than 0.5 (see Figure 1B).
When the tested SNP affects both traits, one can simi-
larly derive the power for each of the three previous tests
against the test of Y1 and Y2. Figure 2 presents such results
for phenotypes with correlation c equal to 0.1 (Figure 2A),
0.5 (Figures 2A and 2B), and 0.9 (Figure 2C), while
assuming G explains 0.5% of the variance of Y1 and be-
tween 0% and 1% of the variance of Y2. Furthermore, we
considered the directionality of the SNP effects for the sec-
ond trait: the same direction as on the first trait (positive
pleiotropy) and effects in opposite directions on the two
traits (negative pleiotropy). Similarly to the previous sce-
nario, the proportion of the total variance explained by
PC1 increases with c, but conversely PC1 displays most of
the genetic effect if G has similar effects on both of the
traits (i.e., is in same direction). This can be explained by
considering vpc1 and vpc2, the proportion of variance ex-
plained by G on the PCs (Equations 7 and 8), for example,
when v1¼ v2¼ v’, vpc2 is null and vpc1 can be approximated
by v0  2=ðc þ 1Þ. Because c is by definition smaller than 1,
the test of PC1 in this specific case will always outperform
the test of each trait independently and the test of PC2.
When the genetic effects are in opposite directions, large
gains in power can be achieved by testing for PC2, whereas
testing for PC1 has almost no power. This is consistent with
the results of Korte et al.,5 where they also observed
increased power to detect genetic variants with pheno-
type-specific effects and negative pleiotropic genetic
effects when accounting for the correlation between the
traits. In the latter case, the effect of G on PC2 can be
approximated by v0  2=ð1 cÞ, so that the effect of G
increases exponentially as the phenotype correlation in-
creases. Although the expected power of the combined
PC approach in all these situations is usually lower than
the power of single PCs when assuming a specific direction
of genetic effect on the traits, it offers a good compromise,
allowing for reasonable power without assuming a specific
hypothesis about the genetic effect. A summary of how the
different tests based on PC1, PC2, and the combined test of
the two PCs behave for moderate sample size is shown in
Table 1.
Comparison of Power for the Analysis of Five
Phenotypes
Whenmore than two phenotypes are considered, deriving
the power of the various analysis strategies quickly be-
comes too complex to be comprehensively expressed. Toerican Journal of Human Genetics 94, 662–676, May 1, 2014 665
Figure 2. Power to Detect a SNP Associated with Two Traits in a Bivariate Analysis
Power at 5 3 108 significance level to detect the SNP associated with the Y. using the independent tests of Y1, Y2, PC1, and PC2 and
a combined PCs test when analyzing 5,000 individuals. The genetic variant has a fixed effect on the trait Y1. The power of each of
the four tests is presented as a function of the effect on the second trait Y2 for three levels of correlation between Y1 and Y2: 0.1 (A),
0.5 (B), and 0.9 (C).compare the power of univariate and multivariate tests in
such a setting, we simulated five phenotypes, Y1 to Y5,
under four different correlation scenarios: (1) a gradient
of moderate to low correlations, (2) a gradient of strong
to low correlations, (3) uniform moderate correlations,
and (4) uniform strong correlations (see Material and
Methods). For each scenario we compared the power of
four approaches: the univariate test of the original pheno-
types, the univariate test of each PC, the test of the PC
displaying the largest genetic effect after correcting for
multiple testing, and the combined test of all PCs. We
simulated and studied cases where the genetic variant is
associated with a single trait (see Figure S1 available online)
and cases where the genetic variant has a pleiotropic effect
(see Figure 3).
No single PC analysis approach was found to have
optimal power for all of the scenarios considered. The asso-
ciation pattern between the SNP and the five components
varied greatly across the set of parameters we used. Some-
times the strongest associations were with the PCs explain-
ing most of the variance (e.g., when the genetic variant is
associated with the 5 traits and the correlation between
the traits is smaller than 0.5); sometimes the strongest
associations were with the PCs explaining the smallest
amount of the total variance (e.g., when the genetic
variant is associated with several, but not all, traits and
there is correlation >0.5 among all traits). Hence, in
most situations, the strategy of testing all PCs and picking
the one with the strongest signal was more efficient than
focusing only on the PCs explaining most of the variance.
However, because most PCs showed association signals,
the combined approach was on average the most powerful
except when SNPs had an effect on a single trait that had
correlation lower than 0.5 with the other traits analyzed,
or in the presence of a fully pleiotropic effect (i.e., the
SNP is associated with all 5 traits) where the correlation
between traits is homogeneous.
In these simulations we considered a variety of sce-
narios, where we varied the correlation structure of the666 The American Journal of Human Genetics 94, 662–676, May 1, 2phenotypes while simulating independently positive
pleiotropic pattern of the tested SNP. When the pleio-
tropic effect reflects the phenotypic correlation (see
Material and Methods), the association patterns (see
Figure S2) were similar to those observed without account-
ing for the correlation among traits (see Figure 3).
Conversely, when we simulated negative pleiotropy (plei-
otropy against the phenotype correlation), we observed
dramatic increases in power for all PC-based approaches
(see Figure S3).
When a Very Large Number of Phenotypes Are
Analyzed
The simulations in the previous section show that when
a relatively small number of phenotypes are analyzed
jointly, the genetic association signal is usually spread
acrossmost or all of the PCs, making the analysis of a single
PC or a subgroup of PCs less powerful as compared to the
combined analysis of all PCs. However, when the number
of phenotypes becomes very large this will not be always
true, because the large increase in the degrees of freedom
can outweigh the benefit in combining many small associ-
ations with individual PCs.
Consider a scenario with a very large number of corre-
lated traits, for example, circulating levels of 100 metabo-
lites. Under such a scenario, when analyzing 2,000
individuals and assuming that the genetic effects are of
the same order of magnitude as in the previous simulations
(i.e., proportion of variance explained between 0.1% and
0.5%), the power of the univariate test of the raw pheno-
types at genome-wide significance level (and before any
correction for the 100 tests conducted) is below 1%.
Depending on the correlation pattern and the level of
pleiotropy, focusing on a subgroup of PCs may increase
power. This is demonstrated in Figure S4, where the power
at 5 3 108 significance level is shown for different tests
when analyzing 100 phenotypes simulated via a gradient
of correlation from 0 to 0.9 (extended model 2 from the
previous section, but with the more complex simulation014
Table 1. Rationale for Testing Genetic Association with PCs in a Bivariate Analysis
Genetic Model PC1 PC2 Combined PCs
bY1s 0 and bY2 ¼ 0 almost no power, converging
to 0 with increase correlation
most powerful for small sample size
and lowbY1; power increases with
correlation
most powerful for large sample size
and large bY1; power increases with
correlation
bY1 in the same direction as bY2 most powerful when correlation
and bY. are moderate
very low power; power increase
slightly with correlation
most powerful when correlation and
bY. are high
bY2 opposite to bY1 almost no power; minor variation
with increase correlation
very powerful; power increase with
correlation
very powerful; power increase with
correlation
The two positively traits are denoted Y1 and Y2 and and genetic effect of G on Y1 (bY1) and Y2 (bY2).scheme SC1 described in Appendix B and Figure S5, and
simulating genetic pleiotropic effects independently of
the phenotypic correlation). We constructed two series of
100 tests by combining either the smallest n PCs that
explain the least amount of the total phenotypic variance
(i.e., the smallest eigenvalues) or the largest n PCs that
explain the largest amount of the total phenotypic vari-
ance (i.e., the largest eigenvalues), with n varying from 1
to 100. When the genetic variant affected 5 traits, we
observed a substantial gain in power when combining
the signal from the 10 PCs corresponding to the 10 small-
est eigenvalues as compared to the combined analysis of all
PCs (power was 0.59 and 0.23, respectively). However,
with the same simulation scheme, that same test (based
on the last 10 PCs) was severely underpowered when the
SNPs were associated with 20 traits (power was 0.63 and
0.99, respectively).
As our simulations demonstrate, the optimal strategy
strongly depends on the underlying model. However, a
naive approach that consists of analyzing the PCs jointly
in a few subgroups based on their eigenvalues can signifi-
cantly improve power. For example, in Figure S4 we show
that combining the joint signal from the PCs with the
largest eigenvalues with the joint signal from the remain-
ing PCs (with the smallest eigenvalues) can increase power
in the two scenarios described above. To achieve this, we
propose Fisher’s method. We defined a global multistep
combined PC (mCPC) score as
TK ¼ 2 
"
log
 
1 F
 XK
i¼1
c2i jK
!!
þ log
 
1 F
 XN
i¼Kþ1
c2i jN  K
!!#
:
(Equation 13)
Here, K is the number of top PCs included in the first
group and N is the total number of PCs. The c2i is the
chi-square association statistic between the SNP and the
ith PC, and Fðc2jdÞ is the cumulative distribution function
of the central chi-square distribution with d degrees of
freedom. Because all PCs are independent, TK follows a
chi-square distribution with 4 degree of freedom under
the null hypothesis of no association with any of the
PCs. Note that this test can easily be extended to more
than two groups.The AmComparison to Other Methods
We compared the power of the combined analysis of all
PCs (CPC) approach against four existing methods: multi-
variate analysis of variance (MANOVA), ordinal regression
of the genotypes against all phenotypes as implemented in
Multiphen,20 multiple trait mixed models (MTMM, see
Appendix C),2,5 and the p value correction method
TATES,8 which combines the p values from standard uni-
variate regression of the phenotype. We did not consider
principal component of heritability, because previous
work found that such methods can be less powerful than
MANOVA.3 Under the scenario described in Figure S2,Mul-
tiphen, MANOVA, MTMM, and CPC perform similarly,
with high gain in power as compared to the univariate
test of each phenotype and TATES (see Figure 4). We also
compared these methods by using 100 simulated pheno-
types under three different generating models: an exten-
sion of the model from Figure S2 (scenario SC1) and two
other models more similar to those used in the TATES
paper.8 Here, the SNPs tested were indirectly associated
with the phenotypes through unmeasured latent variables
driving the phenotypic correlation. We considered both a
small (30) and a very large (1,000) number of latent
variables (scenarios SC2 and SC3, respectively). The details
of the three scenarios are described in Figure S5 and Appen-
dix B, and Figure S6 illustrates the correlation structure and
pleiotropic effects induced in each of the three simulation
schemes. Because we observed inflated false positives for
Multiphen in these settings (see Figure S7), we decided to
exclude it from the 100 phenotype simulations. The
MTMM test was included in these simulations, but we
used the true phenotypic covariance structure instead of
estimating it from the data (see Appendix C). In practice,
estimating the phenotypic covariance structure from the
data, as done in MTMM and other software,27,28 for a large
number of phenotypes (e.g., >10) is computationally
intractable.1
In all of the simulated scenarios, MANOVA was more
powerful than the other methods. However, consistent
with results described above, we observed that the multi-
step combined PC (mCPC) strategy (Equation 13) can
substantially improve power (Figure 5) and outperform
MANOVA in some cases. The optimal number of
groups and number of PCs per group (K in Equation 13)
that will maximize the gain in power depends on theerican Journal of Human Genetics 94, 662–676, May 1, 2014 667
Figure 3. Power Comparison for the Multivariate Analysis of Five Traits in the Presence of Pleiotropic Effect
Power at 5 3 108 significance level for the detection of a genetic variant when analyzing five phenotypes. Between one and five phe-
notypes are simulated as a function of the genetic variant, where its proportion of variance explained was randomly chosen between
0.1% and 0.5%. All genetic effects were positive and the associated phenotypes were randomly selected with equal probability. The
bars represent the power of eight different tests. The univariate tests for each PC are shown in light gray and dark gray after correcting
for the multiple testing, and the univariate test for the most significant PC (tPC) is in blue. The combined test of all five PCs is shown in
black, and the most significant univariate test of all Y. in light green (dark green after correcting for the multiple testing). The power is
shown for four different correlation models and 10,000 simulation replicates with 5,000 individuals.underlying architecture of the traits. For this purpose, the
level of pleiotropy and the phenotypic structure, i.e., the
phenotypic correlation matrix, are probably key compo-
nents. In the case of two groups, if there is marked pheno-
typic structure, then the mCPC approach is unlikely to
improve power whatever the value of K (see Figure 5C
and Figure S6, right panels). If there is nomarked structure,
then the choice of K would mainly depend on the level of
pleiotropy. For low pleiotropy among the correlated traits,
using a high value for K (i.e., combining the top 80% PCs
and the last 20% PCs) might be more powerful (see
Figure 5A and Figure S6, left panels). Conversely, if most
correlated traits shared genetic effects, then using a low
value for K can be more powerful (Figure 5B and Figure S6,
middle panels). Although defining an optimal strategy
would require a fine study exploring various parameters,
these simulations highlight that the multistep combined
PC method can incorporate investigators’ hypotheses
regarding the specific genetic architecture of the correlated
traits, with limited loss of power when the assumption
does not hold.
We then evaluated the robustness and flexibility of the
four methods for handling several issues that commonly668 The American Journal of Human Genetics 94, 662–676, May 1, 2arise in GWASs. We observed that MANOVA, TATES, and
CPC are sensitive to the presence of outliers and can
make the test invalid, whereas Multiphen is not. However,
our simulations showed that the type I error is inflated
only in the presence of a large number of outliers with
values that are an order of magnitude larger than expected
(data not shown). Moreover, deviation from the null hy-
pothesis affects mostly genetic variants with very low fre-
quencies (e.g., MAF < 1% in 1,000 individuals) but have
a small impact on common genetic variants. Contrariwise,
Multiphen suffers from an inflated type I error when the
ratio of number of phenotypes over number of individual
is relatively large (>0.01), e.g., for 50 phenotypes in 1,000
individuals, the lambda value is 1.3 (see Figure S7), whereas
CPC, TATES, and MANOVA do not suffer from this
problem.
We have focused on analyses of unrelated individuals. To
our knowledge, there is no simple extension of MANOVA
or Multiphen to family data. Conversely, for TATES and
CPC, one can easily apply well-established methods such
as mixed models. For illustrative purposes we simulated
10,000 replicates of 200 nuclear families of two parents
and one to five children for a total of 1,000 subjects and014
Figure 4. Power of Alternative Methods for the Multivariate Analysis of Five Traits
A comparison of the power at 53 108 significance level for detecting a genetic variant by five different multiple trait analysis: the com-
bined PCs (CPC, in black); MANOVA (MAN, in red); multitrait mixed model (MTM, in blue); Multiphen (MUL, in orange); and TATES
(TAT, in purple). These tests were applied to five traits where the number of traits with causal genetic effect was varied between one and
five. All genetic effects were positive and associated phenotypes were selected randomly with probability proportional to their level of
correlation with other phenotype. The proportion of variance explained by the causal variant was randomly chosen between 0.1% and
0.5%. The power is shown for four different correlation models and 10,000 simulation replicates with 5,000 individuals.analyzed 10 phenotypes under the null hypothesis of no
association with the tested genotypes. Although applying
any of the tests described above for unrelated individuals
to family data results in an inflated type I error rate, except
for MTMM, applying a mixed model (as implemented in
the software EMMAX29) to the univariate phenotypes
and to the univariate PCs for TATES and CPC, respectively,
solves this issue (Figure 6A). When generating data under
the alternative (Figure 6B), we observed that CPC applied
in conjunction with a mixed model and MTMM had the
highest power (with MTMM being slightly more powerful)
as compared to applying genomic control correction to the
test displaying inflated type I error rate. Overall, the com-
bined PC approach and TATES offer more flexibility than
do integrated approaches such as MANOVA and Multi-
phen. In particular, it is straightforward to apply alterna-
tive tests for association that capture nonlinear effects,
such as the DC test we recently developed30 or tests of ho-
mogeneity of variance by genotypic classes.31,32 As showed
in Figure S8, when applied to the test of variances, CPC hasThe Ama well-calibrated type I error rate under the null whereas
combining signal across univariate phenotypes does not.
GWAS of Coagulation-Related Phenotypes
To illustrate the importance of including principal compo-
nents that explain a small proportion of total phenotypic
variance in the analysis, we conducted a genome-wide
scan of 5 coagulation-related phenotypes in 685 individ-
uals from theMARTHA study, namely fibrinogen (FIB), fac-
tor VIII (FVIII), von Willebrand factor (vWF), the activated
partial thromboplastin time (aPTT), and the standardized
anticoagulant response to Agkistrod on contortrix venom
(ACV). All these phenotypes reflect global coagulation ac-
tivity and display moderate to strong correlation. The cor-
relation matrix between these traits (Table S1) was very
similar to that simulated in model 2, with a gradient of
absolute value correlation varying between 0.75 (FVIII
and vWF) to 0.013 (FIB and aPTT). The five principal com-
ponents extracted from the standardized phenotypes
explained 46.22, 18.86, 18.32, 12.48, and 4.11 percent oferican Journal of Human Genetics 94, 662–676, May 1, 2014 669
Figure 5. Power Comparison for the Multivariate Analysis of 100 Traits
Power at 5 3 108 significance level for seven different tests when analyzing 100 phenotypes across 10,000 replicates. Plots were simu-
lated under schemes SC1 (A), SC2 (B), and SC3 (C) (described in Appendix B and Figure S5). The top, middle, and bottom rows show the
power for low, moderate, and high level of pleiotropy with sample sizes of 3,000, 2,000, and 1,000, respectively. The red curve corre-
sponds to the test combining signals from the n PCs associated with the largest eigenvalues, the dark blue curve corresponds to the
test combining signals on the 101-n PCs associated with the smallest eigenvalues, and the black curve corresponds to the combined
test of latter two tests by the Fisher’s method, with n varying from 1 to 100. The dashed lines correspond to the test of all PCs combined
(gray), MANOVA (red), multitrait mixed model (MTMM, blue), and TATES (purple).the total phenotypic variance, respectively. The individual
trait loadings for each of the five PCs are presented in
Table S2.
All tests we applied showed correct distribution of
p values (Table S3). The results from the univariate analysis
of each original trait and the univariate analysis of each PC
(adjusted for multiple hypothesis testing by Bonferroni
correction) compared to the multivariate analysis of the670 The American Journal of Human Genetics 94, 662–676, May 1, 2PCs were consistent with the conclusions drawn from
the simulation study. All of the five loci that were found
to be genome-wide significant (p < 5 3 108) in a single-
trait analysis were also significant in the combined PC
analysis (Table 2). Conversely, focusing for example on
the top two PCs explaining more than 55% of the variance
as done in Avery et al.13 would have identified only one of
these five SNPs. The combined PCs analysis furthermore014
Figure 6. Multivariate Analysis of Family
Data
Comparison of five multivariate tests for
the analysis of 10 phenotypes in 200 nu-
clear families including two parents and
one to five children for a total of 1,000 sub-
jects. Pairwise phenotypic correlations
follow a gradient from 0 to 0.8 (extended
model 2 from Figure 3).
(A) QQplots and lambda values under the
null hypothesis of no association between
the tested SNP and any of the ten pheno-
types.
(B) Power under the alternative, when
the SNP is associated with three pheno-
types chosen randomly, and proportion
of phenotypic variance explained by the
SNP varying in [0, 0.025]. We compared
MANOVA (red), MultiPhen (orange), TATES (purple), CPC (combined PCs analysis, black), and MTMM (multitrait mixed model,
blue). Under the null, all tests, except MTMM, show inflated type I error rate when the family structure is not accounted for. Applying
a mixed model to the univariate phenotype or univariate PC analysis for TATES and CPC, respectively (dashed lines), solve this issue.
Under the alternative, we applied a genomic control (GC) correction to all tests showing type I error inflation. Power was derived at
a significance level of 5 3 103.identified two variants, one on chromosome 18q21.2
located between two genes, DCC (MIM 120470) and the
RPS8P3 pseudo-gene (p ¼ 1.7 3 108). This SNP was sug-
gestive genome significant based on the univariate analysis
of FVIII (p ¼ 1.7 3 107 and beta coefficient of the coded
allele [allele T against C] of 1.8) and slightly associated
with vWF (p ¼ 0.035 and beta coefficient of 0.89). The
second locus found in the combined PCs analysis was
just below the genome-wide significant level (p ¼ 5.8 3
108). It is located on chr10p11.22 lying between the inter-
esting genes ITGB1 (MIM 135630) and NRP1 (MIM
602069). This SNP had a marginal effect on FVIII and
vWF (the beta coefficients of the coded allele [allele A
against G] were 0.502 and 0.297, respectively) that was
not suggestive of genome-wide association (p value of
6.6 3 107 and 0.0073, respectively).
Several patterns of association observed in the simula-
tion study were also observed in the empirical data. First,
the genetic signal at the most associated loci was spread
out across the PCs with association pattern changing
across loci; thus, focusing only on the univariate signal
from the top PCs was suboptimal. Applying the combined
PCs approach on the top two or three PCs was underpow-
ered for the same reason (data not shown). When the SNP
was associated to a single trait that was moderately
correlated to the others, there was no gain in using
PCA-based approaches (e.g., SNPs rs6025, rs710446, and
rs191945075 in Table 2); however, when the affected trait
had correlation with another trait above 0.5, the combined
PCs had the highest power (e.g., SNPs rs576123,
rs183013917, and rs76854392 in Table 2). Indeed, we
noted that association signals at the additional loci identi-
fied by the combined PCs analysis were driven by signal
from the last PC, which explained 4% of the total pheno-
typic variance. These signals involve nonpleiotropic
effects, or at least unbalance genetic effect on FVIII and
vWF, the most correlated traits. This confirms first thatThe AmPCA of multiple traits can improve detection of both ge-
netic variants harboring pleiotropic effects and those
affecting a single trait; and second that PCs explaining a
low amount of variance can be as important as those ex-
plaining a large amount.Discussion
Principal component analysis is a common tool that has
been widely used for the combined analysis of correlated
phenotypes in genetic linkage and association studies. In
this study we show that PC-based analyses that focus on
the few components explaining most of the phenotypic
variance, as done in many studies, is generally suboptimal.
By deriving the power for PC analysis in a simple case of
two phenotypes and by conducting simulations for more
complex situations, we show that a genetic association
signal may in practice be spread across many or all of the
principal components. Under many realistic scenarios,
important genetic signals, e.g., trait-specific or negative
pleiotropic genetic effects (e.g., positive correlation and
opposite genetic effects), are captured by the PCs explain-
ing the least amount of the total phenotypic variance. We
demonstrated that combining the signal from all PCs can,
therefore, be a more efficient strategy than the standard
PCA approach. Although focusing on only a few PCs is un-
likely to improve statistical power when the total number
of phenotypes analyzed jointly is small (e.g., <10), this is
not necessarily the case when analyzing a very large num-
ber of phenotypes. When considering amore diverse range
of underlying models, involving multiple latent variables
and various patterns of genetic effects, we found that
increase in power can be achieved by applying a naive
multistep approach, where signal on PCs are merged into
subgroups based on their eigenvalues and the association
signal across all groups tested jointly by the Fisher’serican Journal of Human Genetics 94, 662–676, May 1, 2014 671
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672 The American Journal of Human Genetics 94, 662–676, May 1, 2method. This strategy may be worth exploring more
deeply in the future.
We compared the power of the combined PC (CPC)
approach against four existing methods: MANOVA; an
ordinal logistic regression with the genetic variant as the
outcome and the phenotypes as predictors (Multiphen);
a multitrait linear mixed model (MTMM); and the p value
correction method TATES. Overall, CPC showed power
close to the optimal in all of the scenarios considered
while offering more flexibility and robustness than other
methods. In particular, it can account for population and
family structure when applied together with amixed linear
model, which enables applications to family data whatever
the number of traits in a reasonable computation time,
whereas MTMM, for example, would be computationally
intractable for more than 5–10 traits.1 It can also be applied
in conjunction with other univariate tests, e.g., nonpara-
metric tests, or tests of heterogeneity of variance by pheno-
typic classes, an approach now commonly applied in
genomic data.32 Comparatively, MANOVA was the most
powerful approach when a large number of phenotypes
was analyzed (e.g., >50). The performance of Multiphen
was similar to CPC and MANOVA when a small number
of phenotypes was analyzed, but it had an inflated type I
error when the total number of phenotypes analyzed was
large as compared to the number of subjects. However, to
our knowledge, no statistical method has been developed
to account for complex population or family structure in
MANOVA and Multiphen; these methods are therefore
not applicable to family data. The MTMM approach offers
amore global framework than CPC to studymultiple corre-
lated phenotypes, accounting for population structure and
providing additional estimates including the genetic and
environmental variance of each phenotype. However,
this increased complexity comes at a dramatic cost in
computation time so that the approach can be applied to
only a limited number of traits. Although TATES offers sub-
stantial flexibility—it can both handle structured data and
be applied to various statistical tests—this method was
dramatically underpowered as compared to the other
approaches in most scenarios we considered.
In summary, we believe that the combined PC approach
is an attractive approach because it retains relatively good
power across a wide range of alternatives while preserving
computational efficiency. Moreover, as shown in Figure 5,
we can improve the power of CPC by incorporating prior
knowledge about the underlying architecture of the multi-
variate phenotypes, but not for the other approaches.
Finally, we note that performing a meta-analysis across
multiple studies of a multiphenotypes test, including
CPC, is more complex than conducting a meta-analysis
of a univariate test. Simple approaches such as combining
p values across studies by the Fisher’s method are possible,
but more efficient strategies might be developed. We are
actively pursuing this goal.
We simulated a wide range of trait correlation and pleio-
tropic patterns, but no simulation study can be exhaustive.014
It is possible that analyses based on specific mechanistic
hypotheses may be more powerful when the mechanistic
hypotheses hold. But such methods often lose power
when the hypothesized mechanism does not hold. For
example, the recently proposed TATES statistic was shown
to outperform MANOVA in a range of scenarios when the
genetic effect of a SNP was constant across multiple traits
(e.g., v1 ¼ v2 in Equations 1 and 2).8 When we compared
the performance of tests in situations where the genetic
effects varied across traits, TATES had notably less power
than other approaches, including the CPC strategy (Figures
4 and 5). Although there exist situations where some tests
may have more power, we believe the combined PC
approach is an attractive approach because it retains rela-
tively good power across a wide range of alternatives.
This makes the combined PC approach particularly
appealing when the underlying mechanism is unknown.
The genetic variants identified in the MARTHA study at
genome-wide significance level are mostly known variants.
The association between ABO (MIM 110300) and FVIII and
vWF has been known for decades;33,34 the two variants
associated to aPTT (rs710446 in KNG1 [MIM 612358] and
rs1801020 in F12 [MIM 610619]) have been reported pre-
viously;24 and the two loci associated with ACVn, LRP4
(MIM 604270) and F5 (MIM 612309), have already been
described by Oudot et al.21 Two additional variants were
identified by the combined PCs approach at genome-
wide or nearly genome-wide significance level: the SNP
rs183013917 (which is mainly associated with FVIII) and
the SNP rs76854392 near NRP1 (which is associated with
both FVIII and vWF). Although these are potential candi-
dates, especially NRP1 because of previous studies showing
association with angiogenesis (e.g., Vander Kooi et al.35),
they deserve further replication before being confirmed.
A number of studies have used principal component
analysis for the multivariate analysis of correlated pheno-
types. Most of them followed the standard strategy that
consists of reducing the dimension of the outcome data
by focusing on the few components that explain the
most variability in the outcomes and removing those
explaining a low amount of total variance. In this work,
we show that contrary to this widespread practice, testing
the top PCs only can be dramatically underpowered
because PCs explaining a low amount of the total
phenotypic variance can harbor a substantial part of the
total genetic association. We also demonstrate that PCA-
based strategies achieve a moderate gain in power only
in the presence of positive pleiotropy, but have great
potential to detect negative pleiotropy or genetic variants
that are associated with a single trait highly correlated to
others.Appendix A
The proportion of the total variance explained by PC1 and
PC2, respectively s1 and s2, is defined asThe Ams1 ¼ varðPC1Þ
varðY1Þ þ varðY2Þ
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The proportion of variance of PC1 and PC2 explained by
G, respectively vpc1 and vpc2, can be expressed as the ratio
of the genetic effect of G on the variance of PC1 and PC2,
that we denoted t1 and t2, respectively, divided by the total
variance of PC1 and PC2, which are equal to s1 and s2,
respectively
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Appendix B
When simulating 100 phenotypes, we considered three
different simulation schemes (SC1, SC2, and SC3), which
are illustrated in Figure S5. In model SC1 the correlation
between phenotypes is a result of a limited number (30)
of independent latent variables, each affecting 40 pheno-
types on average and explaining altogether 30% of the
total phenotypic variance. The magnitude of the genetic
effects on the phenotypes was generated independently
from the latent variables, but the associated phenotypes
were selected while accounting for the pairwise pheno-
typic correlation. In model SC2, the phenotypic correla-
tion was generated in similar fashion as in model SC1,
i.e., using the same latent variables, but the genetic varianterican Journal of Human Genetics 94, 662–676, May 1, 2014 673
was associated with some of these latent variables but not
directly to the phenotypes. In model SC3, we considered a
more complexmodel involving a thousand latent variables
together explaining 90% of the total phenotypic variance,
subgroups of these latent variables affecting cluster of phe-
notypes. As for model SC2, the genetic variant was associ-
ated with some of the latent variables.
More specifically, in model SC1, the nphe phenotypes
were generated as follows: y ¼ ﬃﬃﬃcp 3ðbt3uÞ þ ﬃﬃﬃgp 3gþﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 g cÞp 3ε, where y is a vector of phenotypic values
for a given subject, g is a SNP, g is the vector of proportion
of variance explained by that SNP on the nphe phenotypes,
u is a vector of realization of nu independent latent vari-
ables U ¼ ðU1;.UnuÞ normally distributed with mean
0 and variance 1, b is a matrix of (positive) weights with
nu rows and nphe columns that defines the contribution
of each variable Ui to the phenotypes (these weights are
defined so that for each phenotype j,
Pnu
i¼1b
2
ij ¼ 1), c is a
vector of nphe weights that defined the proportion of vari-
ance explained by each linear combination bti3ui, and ε,
the residual variance, is a vector of nphe independent vari-
ables, normally distributed with mean 0 and variance 1. In
models SC2 and SC3, the nphe phenotypes were generated
as follows: y ¼ ﬃﬃﬃcp 3ðbt3uÞ þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 cÞp 3ε. A subsample of
the ui were generated as a function of a SNP G such that
ui ¼
ﬃﬃﬃﬃ
di
p
3gþ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 diÞp 3ei, where di is the effect of SNP
on the latent variable Ui, and ei, the residual, is normally
distributed with mean 0 and variance 1.
The parameters c and b and g of the three models were
defined empirically to obtain a similar distribution of pair-
wise phenotypic correlation and a similar distribution of
proportion of variance explained by the PCs. Because the
threemodels were very different, it was difficult to generate
a similar range of genetic effects on the phenotypes. How-
ever, this was of secondary importance because the aim of
this experiment was not to compare the models but to
compare the power of different methods for analyzing
correlated traits under various scenarios. Regardless, with
these constraints, the genetic effects simulated (either
directly on the phenotypes or on the latent variables)
were explaining a very small proportion of the total
phenotypic variance (<0.05%). For example, in model
SC1, the SNP was associated with 10 traits and the variance
that it explained for each phenotype was drawn from a
uniform distribution with minimum 0.1% and maximum
0.5%, so that the total phenotypic variance explained was
on average 0.025%. In model SC2, the SNP had a similar
effect size on 3 latent variables, so that the average contri-
bution of the SNP was 0.007%.Appendix C
For Nphe phenotypes and Nind individuals, a common
modeling for multiple traits mixed model is as follows:
Y ¼ bXT þGþ E, where G ¼ VG5K and E ¼ VE5I, Y is
a column vector of Nphe phenotypes, X is a Nind3Nphe by674 The American Journal of Human Genetics 94, 662–676, May 1, 2Nphe matrix defines as INphe5g where g is a vector of geno-
types for a given genetic variant and b is aNphe vector of its
effect sizes; G is a Nind3Nphe by Nind3Nphe matrix of ge-
netic effects and E is a Nind3Nphe by Nind3Nphe matrix of
residual errors; K is a Nind by Nind relatedness matrix and
I is the Nind by Nind identity matrix; and VG is a Nphe by
Nphe matrix of genetic variance and VE is a Nphe by Nphe
matrix of environmental variance.
Although the standard MTMM test includes estimating
all of the variance components for G and E from the
data, we decided to use the true parameters because esti-
mating variance components for a large set of correlated
traits is computationally intensive. The variance compo-
nent parameters used exclude the effect of the tested
SNP, which leads to a better calibrated statistic and
improved power over the approximate LRT approach
used by MTMM.1 We derived generalized least square esti-
mate for b for each simulated SNP X as follows:
bb ¼ XtV1Y
XtV1X
; where V ¼ Gþ E:
We obtained the p value by using an F-test, where the re-
sidual sum of squares for the null model, RSS0 ¼ YtV1Y,
and the alternative model, RSS1 ¼ ðYXbbÞtV1ðYXbbÞ,
assuming the genotypes and phenotypes have mean zero
and variance one.
Although multivariate mixed models is feasible for a
small number of traits (e.g., Nphe < 10), it becomes compu-
tationally intensive for more traits, because it requires
estimating a large number of dependent covariance
parameters.1,5
For our simulations with unrelated individuals, we
assumed that pairs of different individuals were zero (i.e.,
K ¼ I) and we do not separate genetic and environmental
variance. Under this assumption, deriving V1 can be
simplified to V1 ¼ ðVGþE5IÞ1 ¼ V1GþE5I. Because
VGþE is aNphe byNphe matrix, it can very easily be inverted,
even when analyzing hundreds of traits. Furthermore, the
simple form of V1 allows the derivation of bb, RSS0, and
RSS1 through linear algebra, which avoids saving V1, a
practical and necessary advantage for 100 traits and
1,000 individuals, because such matrix would require
more than 500 Gb of memory.Supplemental Data
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